LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 99 filers reported holding LYELL IMMUNOPHARMA INC in Q1 2023. The put-call ratio across all filers is 3.20 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $241,140 | -53.8% | 164,041 | 0.0% | 0.03% | -53.4% |
| Q2 2023 | $521,650 | +34.7% | 164,041 | 0.0% | 0.06% | +28.9% |
| Q1 2023 | $387,137 | -32.0% | 164,041 | 0.0% | 0.04% | -29.7% |
| Q4 2022 | $569,222 | -52.6% | 164,041 | 0.0% | 0.06% | -58.4% |
| Q3 2022 | $1,202,000 | +12.3% | 164,041 | 0.0% | 0.15% | +23.2% |
| Q2 2022 | $1,070,000 | +29.2% | 164,041 | 0.0% | 0.12% | +60.3% |
| Q1 2022 | $828,000 | -34.8% | 164,041 | 0.0% | 0.08% | -47.7% |
| Q4 2021 | $1,270,000 | – | 164,041 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $131,458,000 | 59.13% |
| Apoletto Ltd | 15,093,969 | $98,413,000 | 27.22% |
| Foresite Capital Management IV, LLC | 13,282,181 | $86,600,000 | 23.32% |
| MIC Capital Management UK LLP | 3,060,569 | $19,955,000 | 3.90% |
| Alphabet Inc. | 5,865,125 | $38,241,000 | 2.08% |
| HSG Holding Ltd | 3,045,997 | $19,860,000 | 1.83% |
| Board of Trustees of The Leland Stanford Junior University | 1,647,882 | $10,744,000 | 0.72% |
| SG3 Management, LLC | 600,000 | $3,912,000 | 0.46% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 157,700 | $1,028,000 | 0.26% |
| Artal Group S.A. | 700,000 | $4,564,000 | 0.24% |